Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels

Posttransplant lymphoproliferative disorders (PTLDs) comprise a wide spectrum of hematologic malignancies that are found increasingly in orthotopic liver transplant (OLT) patients given the rising frequency of these surgeries and their long-term success. PTLDs are highly correlated with both the Eps...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher M. Moore, Ihab Lamzabi, Anne K. Bartels, Shriram Jakate, David H. Van Thiel
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Case Reports in Transplantation
Online Access:http://dx.doi.org/10.1155/2012/952359
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850210749371121664
author Christopher M. Moore
Ihab Lamzabi
Anne K. Bartels
Shriram Jakate
David H. Van Thiel
author_facet Christopher M. Moore
Ihab Lamzabi
Anne K. Bartels
Shriram Jakate
David H. Van Thiel
author_sort Christopher M. Moore
collection DOAJ
description Posttransplant lymphoproliferative disorders (PTLDs) comprise a wide spectrum of hematologic malignancies that are found increasingly in orthotopic liver transplant (OLT) patients given the rising frequency of these surgeries and their long-term success. PTLDs are highly correlated with both the Epstein-Barr virus (EBV) infection and the degree of immunosuppression involved. Herein is reported a case of a 53-year-old male with successfully treated hepatitis C virus genotype 4 and hepatocellular carcinoma who underwent OLT and developed symptoms of weakness and poor appetite 4 years later while on tacrolimus 3 mg b.i.d. with historically very low plasma levels. He was found to be anemic and colonoscopy revealed a 4.5 cm cecal diffuse large B-cell lymphoma (DLBCL). Further workup revealed mesenteric lymph node enlargement consistent and nodal DLBCL dissemination. He was treated with cyclophosphamide-hydroxyldaunorubicin-oncovin-prednisone-rituximab (CHOP-R) chemotherapy and his tacrolimus dose was lowered. Additionally, he manifested PTLD-associated cryoglobulinemia leading to acute kidney injury. After a prolonged hospitalization he was discharged with close followup.
format Article
id doaj-art-913fb5efecae4cf59675516e2f90b074
institution OA Journals
issn 2090-6943
2090-6951
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Case Reports in Transplantation
spelling doaj-art-913fb5efecae4cf59675516e2f90b0742025-08-20T02:09:43ZengWileyCase Reports in Transplantation2090-69432090-69512012-01-01201210.1155/2012/952359952359Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus LevelsChristopher M. Moore0Ihab Lamzabi1Anne K. Bartels2Shriram Jakate3David H. Van Thiel4Section of Hepatology, Rush University Medical Center, Chicago, IL 60612, USASection of Pathology, Rush University Medical Center, Chicago, IL 60612, USASection of Hepatology, Rush University Medical Center, Chicago, IL 60612, USASection of Pathology, Rush University Medical Center, Chicago, IL 60612, USASection of Hepatology, Rush University Medical Center, Chicago, IL 60612, USAPosttransplant lymphoproliferative disorders (PTLDs) comprise a wide spectrum of hematologic malignancies that are found increasingly in orthotopic liver transplant (OLT) patients given the rising frequency of these surgeries and their long-term success. PTLDs are highly correlated with both the Epstein-Barr virus (EBV) infection and the degree of immunosuppression involved. Herein is reported a case of a 53-year-old male with successfully treated hepatitis C virus genotype 4 and hepatocellular carcinoma who underwent OLT and developed symptoms of weakness and poor appetite 4 years later while on tacrolimus 3 mg b.i.d. with historically very low plasma levels. He was found to be anemic and colonoscopy revealed a 4.5 cm cecal diffuse large B-cell lymphoma (DLBCL). Further workup revealed mesenteric lymph node enlargement consistent and nodal DLBCL dissemination. He was treated with cyclophosphamide-hydroxyldaunorubicin-oncovin-prednisone-rituximab (CHOP-R) chemotherapy and his tacrolimus dose was lowered. Additionally, he manifested PTLD-associated cryoglobulinemia leading to acute kidney injury. After a prolonged hospitalization he was discharged with close followup.http://dx.doi.org/10.1155/2012/952359
spellingShingle Christopher M. Moore
Ihab Lamzabi
Anne K. Bartels
Shriram Jakate
David H. Van Thiel
Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels
Case Reports in Transplantation
title Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels
title_full Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels
title_fullStr Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels
title_full_unstemmed Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels
title_short Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels
title_sort colonic diffuse large b cell lymphoma in a liver transplant patient with historically very low tacrolimus levels
url http://dx.doi.org/10.1155/2012/952359
work_keys_str_mv AT christophermmoore colonicdiffuselargebcelllymphomainalivertransplantpatientwithhistoricallyverylowtacrolimuslevels
AT ihablamzabi colonicdiffuselargebcelllymphomainalivertransplantpatientwithhistoricallyverylowtacrolimuslevels
AT annekbartels colonicdiffuselargebcelllymphomainalivertransplantpatientwithhistoricallyverylowtacrolimuslevels
AT shriramjakate colonicdiffuselargebcelllymphomainalivertransplantpatientwithhistoricallyverylowtacrolimuslevels
AT davidhvanthiel colonicdiffuselargebcelllymphomainalivertransplantpatientwithhistoricallyverylowtacrolimuslevels